Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
Kadmon Holdings, Inc. (KDMN)
|
Add to portfolio |
|
|
Price: |
$3.62
| | Metrics |
OS: |
178.5
|
M
| |
-854
|
% ROE
|
Market cap: |
$646
|
M
| |
-64
|
% ROIC
|
Net cash:
|
$18.5
|
M
| |
$0.10
|
per share
|
EV:
|
$628
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($123)
|
M
| |
|
|
EBIT
|
($123)
|
M
| |
|
|
EPS |
($0.70)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 114.9 | 96.7 | 1.4 | 12.3 | 26.1 | 35.7 | 95.0 |
Revenue growth | 18.8% | 6826.4% | -88.6% | -52.9% | -27.1% | -62.4% | |
Cost of goods sold | 0.0 | 0.0 | 0.4 | 4.3 | 7.4 | 3.7 | 6.1 |
Gross profit | 114.9 | 96.7 | 1.0 | 7.9 | 18.7 | 32.0 | 88.9 |
Gross margin | 100.0% | 100.0% | 70.5% | 64.8% | 71.8% | 89.6% | 93.6% |
Selling, general and administrative | 108.6 | 92.9 | 37.6 | 37.1 | 105.9 | 104.7 | 89.3 |
Research and development | | | 49.0 | 40.8 | 35.8 | 33.6 | 32.9 |
EBITA | -115.9 | -33.6 | -87.1 | -76.2 | -113.8 | -83.9 | -16.5 |
EBITA margin | -100.9% | -34.7% | -6242.0% | -621.0% | -436.8% | -234.9% | -17.3% |
Amortization of intangibles | | | | | 15.2 | 27.4 | 21.8 |
EBIT | -115.9 | -33.6 | -87.1 | -76.2 | -129.0 | -111.4 | -38.3 |
EBIT margin | -100.9% | -34.7% | -6242.0% | -621.0% | -495.2% | -311.8% | -40.3% |
Pre-tax income | -109.1 | -61.3 | -54.8 | -79.9 | -208.4 | -147.1 | -64.4 |
Income taxes | -0.2 | 0.0 | -0.5 | -0.1 | 0.3 | 0.0 | 0.0 |
Tax rate | 0.2% | | 1.0% | 0.2% | | 0.0% | 0.0% |
Net income | -108.9 | -61.4 | -56.3 | -81.7 | -230.5 | -147.1 | -64.4 |
Net margin | -94.8% | -63.5% | -4030.3% | -666.1% | -884.6% | -411.8% | -67.7% |
|
Diluted EPS | ($0.66) | ($0.46) | ($0.58) | ($1.42) | ($9.74) | ($18.10) | ($8.27) |
Shares outstanding (diluted) | 166.2 | 132.3 | 97.6 | 57.4 | 23.7 | 8.1 | 7.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|